Transcription Factors and Gene Regulation

TF & Gene Reg Basics - Gene Bosses 101

• Transcription Factors (TFs): Proteins binding specific DNA sequences (promoters, enhancers) to control gene transcription. "Gene Bosses".
• Key TF Domains:
  • DNA-Binding Domain (DBD): Recognizes & binds target DNA. Motifs: Helix-turn-helix, Zinc finger, Leucine zipper.
  • Activation/Repression Domain (AD/RD): Modulates transcription via RNA Pol or co-factors.
• Gene Regulation:
  • Positive: Activator TFs bind DNA → ↑ transcription.
  • Negative: Repressor TFs bind DNA → ↓ transcription.
• TFs ensure precise spatial & temporal gene expression.

⭐ Many TFs act as dimers (homo/hetero), enhancing DNA binding specificity and regulatory options.

Prokaryotic Regulation - Operon Operators

Error: Failed to generate content for this concept group.

Eukaryotic Regulation - Complex Controllers

• General TFs (GTFs): Bind core promoter (e.g., TATA box) with RNA Pol II. Essential for basal transcription.
• Specific TFs (STFs): Bind enhancers or silencers. Modulate transcription rate and specificity.
  • Key Domains: DNA-binding (DBD) & trans-activating/repressing (TAD).
• Cis-Regulatory Elements: DNA sequences.
  • Enhancers: ↑ Gene expression. Act distance/orientation-independently.
  • Silencers: ↓ Gene expression. Similar properties to enhancers.
  • Insulators: Boundary elements; prevent enhancer/silencer cross-talk.
• Chromatin Remodeling: Modifies DNA accessibility.
  • Histone Acetylation (HATs): Euchromatin (active transcription). 📌 "HATS make DNA Happy (Active)".
  • Histone Deacetylation (HDACs): Heterochromatin (transcriptionally silent).
  • DNA/Histone Methylation (DNMTs/HMTs): Often repressive (e.g., CpG islands); context-dependent effects.
• RNA Interference (RNAi): Post-transcriptional gene silencing by siRNAs and miRNAs.

⭐ Locus Control Regions (LCRs) are powerful cis-acting regulatory elements that orchestrate the expression of entire gene clusters, such as the β-globin locus.

Clinical Correlates - When Genes Go Rogue

• p53 (Tumor Suppressor): "Guardian of the genome." Mutations common in many cancers.

  ⭐ p53 gene mutations are implicated in over 50% of human cancers.

• Nuclear Receptor Dysregulation:
  • Androgen Insensitivity Syndrome (AIS): Defective androgen receptor (TF). XY, female phenotype.
  • Vitamin D Resistant Rickets (Type IIA): Mutated Vitamin D Receptor (VDR).
  • Tamoxifen: Selective Estrogen Receptor Modulator (SERM) for breast cancer.
• Developmental Disorders (TF Gene Mutations):
  • HOX gene mutations: Skeletal abnormalities (limb, vertebral).
  • PAX6 mutations: Aniridia (absent iris).
• Neurogenetic Conditions:
  • Rett Syndrome: MECP2 gene (X-linked dominant), affects girls. Neurodevelopmental regression.
  • Huntington's Disease: CAG repeats in HTT gene; mutant Huntingtin impairs TFs.

High‑Yield Points - ⚡ Biggest Takeaways

• Transcription Factors (TFs) bind specific DNA sequences (e.g., enhancers, promoters) to regulate gene expression.
• General TFs (e.g., TFIID) are essential for basal transcription initiation by RNA Polymerase II.
• Specific TFs mediate cell-type specific or signal-dependent gene regulation.
• Key DNA-binding domains include zinc fingers, helix-turn-helix, and leucine zippers.
• Activators recruit coactivators (e.g., HATs); repressors often recruit corepressors (e.g., HDACs).
• Epigenetic modifications like DNA methylation and histone acetylation critically influence TF access and gene activity.
• Hormone-receptor complexes act as TFs to directly regulate gene expression (e.g., steroid hormones).